Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patientsSotrovimab, 면역 저하 환자에서 SARS-CoV-2 오미크론 변이 진화 촉진 Published on 2022-08-012022-09-11 Journal: The Lancet. Microbe [키워드] Evolution Immunocompromised patient Omicron variant SARS-CoV-2 Sotrovimab [저자] Grégory Destras, Antonin Bal, Bruno Simon, Bruno Lina, Laurence Josset [Category] COVID19(2023년), SARS, 변종, 진단, PMC URL [DOI] 10.1016/S2666-5247(22)00120-3 [Article Type] Article [Source] PMC All Keywords 【제목키워드】 Evolution, SARS-CoV-2, Immunocompromised patient, Omicron variant, Sotrovimab,